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MAJOR ARTICLE 
Prospective Assessment of the Etiology of Acute 
Febrile Illness after a Tick Bite in Slovenia 
Stanka Lotric-Furlan,' Miroslav Petrovec,2 Tatiana Avsic-Zupanc,2 William L. Nicholson,3 John W. Sumner,3 
James E. Childs,3 and Franc Strle' 
'Department of Infectious Diseases, University Medical Centre, and 2Medical Faculty, Institute for Microbiology and Immunology, 
Ljubljana, Slovenia; nd 3Viral nd Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta 
A prospective study established the etiology of febrile illnesses in residents of Slovenia that occurred within 
6 weeks after a tick bite. A combination of laboratory and clinical criteria identified 64 (49.2%) of 130 patients 
as having confirmed, probable, or possible cases of tickborne disease during 1995 and 1996. Of the 130 patients, 
36 (27.7%) had laboratory evidence of tickborne encephalitis, all of whom had clinically confirmed disease. 
Evidence of infection with Borrelia burgdorferi sensu lato was identified in 26 patients; 10 (7.7%) had confirmed 
Lyme borreliosis. Of 22 patients with evidence of Ehrlichia phagocytophila infection, 4 (3.1%) had confirmed 
ehrlichiosis. Infection by multiple organisms was found in 19 (14.6%) of 130 patients. Patients with meningeal 
involvement (43 [72.3%] of 59) were more likely to have confirmed tickborne disease than were patients with 
illness of undefined localization (18 [26.5%] of 68; P<.0001). Tickborne viral and bacterial infections are an 
important cause of febrile illness in Slovenia. 
Slovenia, a small central European country with 2 mil- 
lion inhabitants, has been recognized for >50 years as 
a region where tickborne encephalitis (TBE) is endemic, 
and since 1986, Lyme borreliosis has also been known 
to be endemic there. The annual incidence of both 
diseases is among the highest in Europe [1]. In 1998, 
we documented the first 4 cases of human granulocytic 
ehrlichiosis (HGE), caused by Ehrlichia phagocytophila, 
in Slovenia, indicating the presence of yet another en- 
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demic tickborne pathogen [2]. Ixodes ricinus, the most 
common tick species in Slovenia, is the main vector of 
all 3 pathogens [3, 4]. This tick is widely dispersed in 
Slovenia, a country of 20,256 km2, of which one-half 
is covered by forests. 
Every summer, numerous patients with febrile ill- 
nesses that have occurred after a tick bite are seen by 
physicians at our medical center. The etiology of these 
illnesses has never been systematically examined. 
Herein we summarize the results of a prospective study 
in which we combined clinical criteria with laboratory 
diagnostic confirmation to establish the etiology of feb- 
rile illnesses occurring in a cohort of patients enrolled 
during a 2-year period. 
PATIENTS AND METHODS 
Prospective enrollment. From January 1995 through 
December 1996, we enrolled patients who presented 
with possible tickborne infection to the Department of 
Infectious Diseases, University Medical Centre, Ljub- 
ljana, Slovenia. Enrollment criteria included fever (tem- 
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perature a38?C), history of a tick bite (received within the 
previous 6 weeks), age >15 years, and no obvious other cause 
of the illness (such as community-acquired pneumonia, urinary 
tract infection, erysipelas, or sepsis). At first visit, patients were 
assigned to 1 of 3 clinical groups on the basis of the following 
criteria: (1) erythema migrans present, (2) possible meningeal 
involvement, and (3) localization of illness undefined. 
Specimen collections. From each patient, an acute-phase 
serum specimen and EDTA-anticoagulated whole blood spec- 
imen were collected. Additional patient evaluations and serum 
collections were done at 14 days and at 6-8 weeks after the 
onset of disease. Lumbar puncture was performed if meningeal 
involvement was suspected. 
Clinical laboratory testing. At the first visit, Giemsa- 
stained peripheral blood smears were examined by light mi- 
croscopy for the presence of ehrlichial morulae within leuko- 
cytes. A complete blood cell count and serum chemistry profile 
were determined at each evaluation. Cell counts and concen- 
trations of total protein, immunoglobulin, glucose, and albu- 
min in CSF samples were determined. 
Culture of Borrelia burgdorferi sensu lato. For patients 
with erythema migrans, a biopsy specimen was obtained from 
the periphery of the skin lesion, as described elsewhere [5], and 
it was cultured in modified Kelly-Pettinkofor medium mon- 
obasic potassium phosphate medium [6]. CSF specimens were 
also cultured in modified Kelly-Pettinkofor medium for the 
presence of borreliae. 
Diagnostic testing of serum and CSF samples. The pres- 
ence of IgM and IgG antibodies to TBE virus was assessed by 
means of ELISA (Immunozyme, FSME; Immuno AG), per- 
formed according to the manufacturer's instructions. Dem- 
onstration of the presence of IgM antibodies to TBE virus or 
seroconversion by IgG ELISA (after negative findings at initial 
examination) in sequentially obtained serum samples was con- 
sidered an indicator of a recent infection. The presence of IgG 
antibodies without IgM, in unchanging titers, was interpreted 
as evidence of previous TBE. 
We used indirect immunofluorescence assays (IFAs) to test 
for presence of IgM and IgG antibodies to whole cells of a local 
isolate of Borrelia afzelii [7], E. phagocytophila ntigens [8], 
Ehrlichia chaffeensis antigens (MRL Diagnostics), and Rickettsia 
conorii antigens (bioMerieux). For the purposes of this study, 
serum antibody titers > 1:256 for B. burgdorferi sensu lato, > 1: 
128 for E. phagocytophila or E. chaffeensis, and >1:80 for R. 
conorii were interpreted as positive. Antiborrelial IFA IgM and 
IgG antibody titers in CSF 1:8 were interpreted as positive. 
Intrathecal borrelial-antibody production was demonstrated by 
a B. burgdorferi IgM and/or IgG index >2 [9]. 
PCR assays. DNA was extracted from leukocytes eparated 
from blood in the buffy coat and used as a template for PCR 
assays to detect DNA from the E. phagocytophila genogroup 
and E. chaffeensis as described elsewhere [2]. The primers used 
were 16S rRNA gene primers GE9f and GElOr and nested 
primer sets (HS1/HS6 followed by HS43/HS45) that target the 
GroESL operon of ehrlichiae [4]. 
Case definitions. A case of TBE was considered confirmed 
by the following findings: fever, clinical signs/symptoms of 
meningitis or meningoencephalitis, an elevated CSF cell count 
(>5 X 106 cells/L), and serum IgM antibodies to TBE virus 
and/or IgG seroconversion to TBE virus. 
A case of Lyme borreliosis was considered confirmed by the 
following findings: erythema migrans and/or other typical or 
highly suggestive clinical signs (e.g., lymphocytoma, Bann- 
warth's syndrome, or meningitis) and 1 of the following: (1) 
isolation of B. burgdorferi sensu lato from skin or CSF, (2) 
seroconversion to borrelial antigens, or (3) B. burgdorferi sensu 
lato intrathecal antibody production. Patients who met the clin- 
ical criteria but not the strict laboratory-test criteria and had 
positive borrelial serum antibody titers were considered to have 
probable Lyme borreliosis. Patients with febrile illness who did 
not fulfill the clinical requirements but had laboratory evidence 
of borrelial infection were considered to have possible Lyme 
borreliosis. 
A case of HGE or human monocytic ehrlichiosis (HME) was 
considered confirmed by the following findings: fever and se- 
roconversion, or a 4-fold change in serum antibody titer to E. 
phagocytophila or E. chaffeensis antigens, and/or a positive PCR 
with subsequent sequencing of the amplicons that demon- 
strated Ehrlichia-specific DNA. A case of acute HGE or HME 
was defined as probable if the patient had fever and acute and 
convalescent serum samples with unchanging IFA titers (i.e., 
62-fold difference) of antibodies to E. phagocytophila or E. 
chaffeensis antigens ( 1:128). A case of HGE or HME was 
considered possible if the patient had serum samples with a 
titer of 1:128 of antibodies to E. phagocytophila or E. chaf- 
feensis at only 1 testing point. 
Data analysis. Differences in quantitative data were an- 
alyzed by Kruskal-Wallis tests, and differences in qualitative 
data by the x2 or Fisher's exact test, with use of Epi Info soft- 
ware, version 6.04 (Centers for Disease Control, Atlanta). All 
P values were 2-tailed; those <.05 were considered statistically 
significant. 
RESULTS 
Frequency of tickborne disease. During the 2-year study, 130 
patients were enrolled and 64 (49.2%) received a diagnosis of 
1 tickborne disease. The most common disease was TBE, 
followed by Lyme borreliosis and HGE (table 1). A single di- 
agnosis was made for 45 individuals, whereas 19 patients were 
potentially infected with >1 tickborne organism. No cases of 
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Table 1. Confirmed, probable, and possible etiologies of febrile illnesses following a tick bite for 130 individuals in Slovenia. 
No. (%) 
Diagnosis and case classification of patients Method of determinationa 
Tickborne encephalitis, confirmed 36 (27.7) IgM antibody and clinical signs of aseptic meningitis (n = 36) 
Lyme borreliosis 
Confirmed 10 (7.7) Clinically compatible disease and isolation of B. burgdorferi (n = 3), seroconversion 
(n = 7), or development of intrathecal antibodies (n = 7) 
Probable 3 (2.3) Stationary antibody titers and clinically compatible disease 
Possible 13 (10.0) Antibody and fever; no other clinical signs 
Human granulocytic ehrlichiosis 
Confirmed 4 (3.1) PCR demonstration of ehrlichial DNA (n = 3) or seroconversion (n = 4) 
Probable 14 (10.8) Multiple antibody titers 2 1:128 
Possible 4 (3.1) Single antibody titer >1:128 
Human monocytic ehrlichiosis 
Confirmedb 1 (0.8) Seroconversion 
Probable 2 (1.5) Multiple antibody titers 1:128 
a More than 1 method of determination may have been used to identify a single case. b Diagnosis of HGE was also confirmed. 
Mediterranean spotted fever were diagnosed (on the basis of 
detection of R. conorii antibodies). 
Cases of TBE. Cases of TBE were confirmed by detection 
of IgM antibodies in 36 (27.7%) of 130 patients; in all 36, IgG 
antibodies were also found. Antibodies reactive to >1 addi- 
tional tickborne organism were present in 13 (36.1%) of the 
36 patients with TBE (table 2). 
All 36 patients with IgM antibodies to TBE virus had lym- 
phocytic meningitis or meningoencephalitis. A typical biphasic 
course of illness was established for 25 (69.4%) of 36 patients. 
All 7 patients who were seronegative at initial examination (as 
determined by IgM ELISA) seroconverted in within 6 weeks 
after the onset of illness. 
An additional 26 (20%) of the 130 enrolled patients had IgG 
but not IgM antibodies to TBE virus (data not shown). Three 
of these 26 (11.5%) had been vaccinated against TBE, and 14 
(53.8%) had a history of TBE. Nine patients (34.6%) had no 
history of illness compatible with meningitis, a circumstance 
that suggests they may have had asymptomatic infections with 
TBE virus in the past. 
Cases of Lyme borreliosis. Overall, 10 (7.7%) of 130 pa- 
tients with confirmed borreliosis were identified by :1 diag- 
nostic methods (table 1). Isolates of B. burgdorferi sensu lato 
were obtained from the skin lesions of each of the 3 febrile 
patients with erythema migrans. In 7 patients who had CSF 
samples with detectable borrelial-antibody titers, evidence of 
intrathecal antibody production was detected (median B. burg- 
dorferi IgG index, 7.3; range, 3.2-10.7), and 6 of these 7 patients 
had lymphocytic meningitis. An additional 7 patients serocon- 
verted to borrelial antigens, including 3 in whom production 
of borrelial intrathecal antibody was also detected. 
In addition to the 10 patients with confirmed cases of Lyme 
borreliosis, 3 patients with probable cases (2.3% of enrolled 
patients) were identified. Each patient had meningitis and no 
positive borrelial serum antibody titers. In addition, 13 patients 
with possible Lyme borreliosis (10%) were found to have pos- 
itive borrelial-antibody titers, but without characteristic clinical 
signs of Lyme borreliosis. Two possible cases involved previ- 
ously diagnosed Lyme borreliosis, but no clinical information 
on previous borrelial infection was elicited in the remaining 11 
cases. 
Several cases in which there was evidence of B. burgdorferi 
sensu lato infection met the criteria for diagnosis of an alter- 
native disease, most often TBE (table 2). Among confirmed 
cases of Lyme borreliosis, 6 of 10 (60%) also fulfilled the criteria 
for TBE; all 3 patients with probable Lyme borreliosis had TBE, 
but none of the 13 patients with possible Lyme borreliosis had 
TBE (table 2). Overall, antibody to >1 tickborne organism was 
found significantly more often in patients with confirmed Lyme 
borreliosis than in patients without obvious clinical signs (7 of 
10 vs. 3 of 13; P = .0397). 
Cases of HGE. Although no intracytoplasmic morulae in 
leukocytes were found on any blood smear examinations, IgG 
antibodies to E. phagocytophila at a titer 1:128 were found 
in 22 patients (16.9%). Four patients had confirmed HGE di- 
agnosed on the basis of seroconversion to E. phagocytophila 
antigens (table 1). 
For 3 of 4 patients with serologically confirmed cases of HGE, 
PCR analysis with use of 16S rRNA primers GE9f/GE10r and 
the GroESL primers generated products of the expected sizes 
(919 bp and 480 bp, respectively) from DNA extracted from 
blood samples obtained at the first visit. Sequencing of these 
amplicons confirmed the DNA to be of ehrlichial origin, as 
reported elsewhere [2]. 
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In 14 (63.3%) of 22 patients, titers of antibody to E. phago- 
cytophila were consistently 1:128 in repeated tests, meeting 
the study criteria for probable HGE. In addition, 4 (18.2%) of 
22 patients met the criteria for possible HGE. However, 3 had 
a reliable alternative explanation for their illness; all 3 fulfilled 
study criteria for TBE and 1 also for neuroborreliosis (table 2). 
In 13 (59.1%) of the 22 patients with antibodies to E. phago- 
cytophila, serum antibodies to other tickborne organisms were 
also detected (table 2). Seven (50%) of the patients with prob- 
able HGE met the study criteria for a confirmed, probable, or 
possible case of another tickborne disease: for 4 patients, TBE 
(2 of these 4 also fulfilled criteria for confirmed Lyme borre- 
liosis); for 2 patients, possible Lyme borreliosis; and for 1, prob- 
able acute HME. 
Cases of HME. None of the 3 patients with antibodies to 
E. chaffeensis had PCR results that were positive for this or- 
ganism. Serum antibodies from all 3 of these individuals were 
dually reactive to E. chaffeensis and E. phagocytophila antigens, 
and it is likely that these infections were caused by E. 
phagocytophila. 
Testingfor R. conorii. Serum antibodies to R. conorii were 
not detected in any of the patients studied. 
Clinical and epidemiologicalfeatures ofpatients. The 130 
patients were assigned to 1 of 3 clinical groups on the basis of 
the following criteria: erythema migrans present (3 patients 
[2.3%]), possible meningeal involvement (59 patients [45.4%]), 
and localization of illness undefined (68 patients [52.3%]). 
Overall, there was a slight excess of males in the study popu- 
lation (71 patients [54.6%]; table 3). 
Erythema migrans. The 3 patients with erythema migrans 
were women aged 36, 45, and 55 years. The median duration 
of the incubation period from tick bite to onset of disease was 
11 days (range, 10-14 days), and the median duration of fever 
was 4 days (range, 3-5 days; table 3). B. burgdorferi sensu lato 
was isolated from biopsy specimens of the skin lesion in all 3 
cases. 
Patients with possible meningeal involvement and illness 
of undefined localization. Our success in establishing an 
etiology for disease was significantly higher for patients with 
signs of meningeal involvement (43 [72.3%] of 59; ) than for 
patients with illness of undefined localization (18 [26.5%] of 
68 patients; P<.0001). The most frequent diagnosis among 
patients with clinically suspected meningitis was TBE (table 4). 
The diagnosis of TBE was limited to this group and, even 
among them, limited to patients with lymphocytic meningitis. 
The group with suspected meningitis was also more likely to 
have diagnostic test results that were concurrently positive for 
an additional tickborne organism (table 4). 
Patients with possible meningeal involvement were younger, 
had a longer duration of fever, and were more likely to be 
Table 2. Results of serological testing for multiple tickborne 
pathogens in 130 patients with an acute febrile illness following 
a tick bite. 
No. (%) of 
Antigen(s) to organism seropositive patientsa 
TBE virus only 23 (36.5) 
Borrelia burgdorferi sensu lato only 12 (19.1)b 
Ehrlichia phagocytophila only 9 (14.3) 
Ehrlichia chaffeensis only 0 
Rickettsia conorii 0 
TBE virus, B. burgdorferi sensu lato 6 (9.5) 
TBE virus, E. phagocytophila 4 (6.4) 
TBE virus, E. phagocytophila, B. burgdorferi 
sensu lato 3 (4.8) 
E. phagocytophila, B. burgdorferi sensu lato 3 (4.8)c 
E. phagocytophila, E. chaffeensis 2 (3.2) 
E. phagocytophila, E. chaffeensis, 
B. burgdorferi sensu lato 1 (1.6) 
NOTE. TBE, tickborne encephalitis. 
a Of 130 patients who were tested for antibodies to different tickborne 
pathogens, 63 (48.7%) were seropositive to >1 of the tested pathogens. 
b In addition to 12 patients with positive serology, laboratory evidence of 
infection was demonstrated in one seronegative patient with erythema mig- 
rans by the isolation of B. burgdorferi sensu lato from the skin lesion. 
c One patient with meningitis had only a positive CSF IgG antibody titer to 
B. burgdorferi sensu lato. 
hospitalized than patients with localization of illness undefined 
(table 3). The majority of patients with possible meningeal 
involvement presented from May through October, similar to 
when patients with illness of undefined localization presented 
(from April through November). Patients with clinical signs of 
meningitis were more likely to recall multiple tick bites during 
the 6 weeks prior to the onset of illness (table 3). 
Of the 59 patients with clinical signs of meningeal involve- 
ment, CSF examination revealed lymphocytic meningitis in 42 
(71.2%). The 42 patients with abnormal CSF findings differed 
in several ways from the 17 patients for whom there was clinical 
suspicion of meningitis but whose CSF findings were normal. 
Patients with abnormal CSF findings were older (median of 
45.5 years [range, 17-85 years] vs. median of 27 years [range, 
18-58 years]; P< .001), had shorter incubation periods (median 
of 7 days [range, 2-24 days] vs. median of 14 days [range, 5-30 
days]; P = .002), and tended to have a longer duration of fever 
(median of 7 days [range, 2-15 days] vs. median of 5 days 
[range, 2-13 days]). These 2 classes of patients did not differ 
with regard to sex, number of tick bites, and hospitalization 
rate. 
DISCUSSION 
Tickborne pathogens are a significant cause of morbidity in 
Europe and North America, where there are tens of thousands 
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Table 3. Findings for patients with an acute febrile illness following a tick bite. 
Diagnosisa 
Possible meningeal Localization of 
Erythema migrans involvement illness undefined 
Variable (n = 3) (n = 59) (n = 68) pb 
Sex, male/female 3/0 26/33 30/38 .862c 
Age, years 
Mean + SD 45.3 44.7 + 16.9 33.5 + 14.6 .002d 
Median (range) 45 (36-55) 41 (16-85) 33 (16-70) 
Incubation period, days 
Mean ? SD 11.7 11.3 ? 5.6 11.9 ? 7.0 .970d 
Median (range) 11 (10-14) 10 (2-30) 11 (2-30) 
Duration of fever, days 
Mean ? SD 4.0 6.8 ? 3.0 5.3 ? 2.9 .007d 
Median (range) 4 (3-5) 7 (2-15) 5 (2-21) 
Patient characteristics, 
no. (%) of patients 
Hospitalized 2 (67) 54 (92) 3 (5) .000c 
>1 Tick bitee 0 29 (49.2) 16 (23.5) .004C 
a For case definitions see Methods. b Comparison of the group of patients with possible meningeal involvement and the group with localization 
of illness undefined. 
c 
x2 test (2-tailed). 
d Kruskal-Wallis test. 
e During the 6 weeks prior to onset of the present illness. 
of cases of Lyme borreliosis annually [10]. Other tickborne 
pathogens, including viruses (e.g., TBE virus) and intracellular 
bacteria (e.g., Rickettsia rickettsii, E. chaffeensis, and E. phago- 
cytophila), can cause fatal infections in humans [11, 12]. Few 
studies have attempted to identify the varied etiologies of febrile 
illnesses occurring in persons with a history of a recent tick 
bite. 
Most studies exploring the disease burden posed by tickborne 
pathogens have relied on indirect measures of tick exposure 
rather than a history of a recent tick bite. These studies involve 
selecting cohorts of persons exposed to tick-infested habitats 
[13, 14], choosing study populations from locations where tick- 
borne diseases are endemic [ 15, 16], or testing samples obtained 
from patients hospitalized during the summer months with 
fevers of unknown origin [17]. Relatively few studies have 
looked at cohorts or case series of ill patients with a history of 
recent tick bite, although a number of studies have prospectively 
followed patients who received tick bites, to assess the risk of 
becoming ill [18, 19] and to assess the effectiveness of pro- 
phylactic antibiotic treatment [20, 21]. Examining febrile pa- 
tients with a known history of tick bite has been instrumental 
in identifying diseases caused by newly described pathogens, 
such as HME caused by E. chaffeensis [22, 23]. 
In our study we attempted to determine the etiology of acute 
febrile illness in adults who had been bitten by a tick in a 
central European country where several tickborne diseases are 
endemic. We examined patients for laboratory evidence of 
HME and Mediterranean spotted fever, in addition to Lyme 
borreliosis, TBE, and HGE. We were able to ascribe an etiology 
for the illness in >49% of the enrolled patients. 
It was not surprising that for more than one-half of the 
patients with a history of tick bite in the 6 weeks before onset 
of illness, a specific tickborne illness could not be diagnosed. 
There are many febrile illnesses that occur during "tick season" 
that are unrelated to the occurrence of a coincidental tick bite. 
In addition, we did not test for diseases caused by other tick- 
borne organisms (e.g., babesiosis). Since novel tickborne path- 
ogens of humans continue to be described (e.g., Ehrlichia ewin- 
gii) [24], it is possible that some cases of tickborne disease 
might have been missed (although E. ewingii is not known to 
occur in Europe). 
Among patients with laboratory evidence of a disease caused 
by a tickborne organism, the most common infections diag- 
nosed were due to TBE virus (36 of 130 patients), B. burgdorferi 
sensu lato (26 of 130), and E. phagocytophila (22 of 130). A 
number of the patients had evidence of >1 infection, although 
in most cases a more likely etiology could be identified. Se- 
rological evidence of infection with E. chaffeensis was found in 
3 patients. However, we believe these individuals were infected 
by E. phagocytophila and that HGE was the only ehrlichial 
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Table 4. Diagnosis according to case definitions of study for patients with an acute febrile 
illness following a tick bite. 
No. (%) of patients with diagnosis 
Possible meningeal Localization of 
Erythema migrans involvement illness undefined 
Diagnosisa (n = 3) (n = 59) (n = 68) pb 
TBE (all) 0 36/59 (61.0) 0/68 0 
TBE only 0 23/36 (63.9) 0 
TBE and >1 other 0 13/36 (36.1) 0 
LB (all) 3/3 13/59 (22.0) 10/68 (17.2) .402 
Confirmed 3/3 7/13 (53.8) 0 .008 
Probable 0 3/13 (23.1) 0 .229 
Possible 0 3/13 (23.1) 10/10 (100) .000 
LB only 3/3 3/13 (23.1) 7/10 (70) .040 
LB and 31 other 0 10/13 (76.9) 3/10 (30) .040 
HGE (all) 0 11/59 (18.6) 11/68 (16.2) .895 
Confirmed 0 1/11 (9.1) 3/11 (27.3) .587 
Probable 0 6/11 (54.5) 8/11 (72.7) .659 
Possible 0 4/11 (36.4) 0 .090 
HGE only 0 3/11 (27.3) 6/11 (81.8) .387 
HGE and >1 other 0 8/11 (72.7) 5/11 (18.2) .387 
HME (all) 0 0 3/68 (4.4) 
Confirmed 0 0 1/3 (33.3) 
Probable 0 0 2/3 (66.7) 
HME only 0 0 0 
HME and >1 other 0 0 3/3 (100) 
Etiology, no. of organisms 
0 0 16/59 (27.1) 50/68 (73.5) .000 
1 3 29/59 (49.2) 13/68 (19.1) .001 
>1 0 14/59 (23.7) 5/68 (7.6) .020 
NOTE. HGE, human granulocytic ehrlichiosis; HME, human monocytic ehrlichiosis; LB, Lyme borreliosis; TBE, 
tickborne encephalitis. 
a According to the case definitions used in this study; see Methods. 
b Comparison of the group of patients with possible meningeal involvement and the group of patients with 
localization of illness undefined, as determined by x2 or Fisher's exact test (2-tailed). 
disease that occurred in our patient cohort. In the United States, 
some individuals' serum samples are reactive to both E. chaf- 
feensis and E. phagocytophila antigens [25], which indicates the 
potential for cross-reactive antibodies to develop. 
In many of the cases in which laboratory findings indicated 
tickborne infection, our strict case-definition criteria for con- 
firmed disease were met unambiguously. All the patients with 
a febrile illness and IgM antibody to TBE virus had lymphocytic 
meningitis. However, only 10 of 26 patients with laboratory 
evidence of infection with B. burgdorferi sensu lato met the 
study criteria for confirmed Lyme borreliosis; similarly, that 
diagnosis could be confirmed for only 4 of 22 patients with 
laboratory evidence of HGE. 
We must stress that our case definitions were intentionally 
strict and presumably resulted in some classification of cases 
as probable or possible when patients presented with gener- 
alized complaints. For example, a confirmed diagnosis of Lyme 
borreliosis required the presence of typical clinical signs of the 
disease. Thus, patients without typical disease were classified 
as having possible Lyme borreliosis, even if laboratory analyses 
indicated either recent seroconversion or evidence of specific 
intrathecal antibody production. Asymptomatic Lyme borre- 
liosis is relatively frequent; therefore, seroconversion alone is 
not proof of the etiology of the current febrile disease [26]. 
Furthermore, intrathecal antibody production is a well-rec- 
ognized and important laboratory indicator ofneuroborreliosis, 
but it may persist with normal CSF cell counts for several 
additional months or even years after acute infection [27]. 
An additional finding of interest in this study was the high 
level of antibodies to tickborne organisms, which indicated 
remote rather than acute infection. As an example, the number 
of patients with solely IgG antibody to TBE virus in our study 
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was high (26 [20%] of 130 patients) yet within the range ex- 
pected for regions where this disease is endemic [28]. However, 
even with an average incidence of TBE of 20 cases per 100,000 
residents in central Slovenia [29], it is still striking that 14 of 
130 patients had a history of TBE. Similarly, 16 of 130 patients 
(12.3%) had possible or probable Lyme borreliosis. A back- 
ground seroprevalence of 5.3% has been described with regard 
to an adult population in rural central Slovenia [30]. No pub- 
lished data exist on the background prevalence of antibodies 
reactive to Ehrlichia antigens in adult Slovenian populations. 
The currently studied patient population in central Slovenia 
was highly exposed to ticks and at high risk for acquiring mul- 
tiple tickborne pathogens. A relatively large proportion of pa- 
tients had laboratory indications of infection with >1 tickborne 
organism, and several patients fulfilled the diagnostic criteria 
for >1 disease. In Slovenia, TBE virus, E. phagocytophila, and 
B. burgdorferi sensu lato can be transmitted by I. ricinus, thus 
increasing the potential risk for multiple infection. In fact, con- 
comitant infections with TBE virus and B. burgdorferi sensu 
lato have been described in patients with acute meningitis [31]. 
Our study revealed that HGE is also present in this area. In 
the United States, it has been experimentally demonstrated that 
dually infected ticks can simultaneously transmit B. burgdorferi 
and E. phagocytophila [32], and serological evidence of anti- 
bodies to multiple tickborne organisms is not uncommon [16, 
33]. Unfortunately, the small number of patients in our 3 sub- 
groups did not permit extensive comparisons of clinical and 
laboratory characteristics between individuals who had a single 
infection and those who met the definition for multiple infec- 
tion. The potential clinical relevance of combined infections 
remains to be defined. 
It should also be noted that by restricting our study to adult 
febrile patients with a known history of tick bite, we may have 
missed many cases of tickborne disease presenting at our med- 
ical center. Our study was not designed to assess the burden 
of tickborne disease in children <15 years of age. In addition, 
the percentage of persons recalling a tick bite prior to devel- 
oping a tickborne illness varies, but reported values are 68% 
for TBE in Germany [34] and 73% for erythema migrans in 
Slovenia [35]. In the United States it is estimated that ~73% 
of patients with HGE [36] and 68% of patients with HME [37] 
recall receiving a tick bite prior to their illness. 
Our ability to identify etiologic agents was greater for patients 
with symptoms and signs of CNS involvement or erythema 
migrans than for patients with illness of undefined localization. 
The most important reason for this difference was that TBE 
virus caused disease solely in the group of patients who had 
meningitis. 
Definitively documenting the etiology of meningitis for pa- 
tients with borrelial infection was more difficult. The essential 
criterion for proven neuroborreliosis among patients with men- 
ingitis is the intrathecal production of borrelial antibodies. To 
prove local antibody synthesis, it is necessary to show that CSF 
antibody titers are higher than they would be expected to be 
due to leakage from serum into CSF. Although various formulas 
have been applied for the assessment of intrathecal antibody 
production, it is generally agreed that the CSF:serum antibody 
index should be >2 [9, 38]. Unfortunately, calculating such 
indices on the basis of IFA titers of 2-fold serial dilutions is an 
approximate method, because inexact readings can amplify in- 
accuracies. Typically, IFA titers within a single dilution (i.e., a 
2-fold difference) are not considered significantly different, as 
this range of variation is inherent to the test. However, such 
variation can dramatically effect indices based on end- 
point-titer ratios. To be significant, index values should prob- 
ably be >4. Elevated indices in our patients range from 3.2 to 
10.7. In 6 of 7 patients the index was >4; in 3 of the 7 patients, 
including the patient with an index of 3.2, seroconversion to 
borrelial antigens was also established. 
With the combined clinical and laboratory methods used in 
our study, tick-transmitted iseases were diagnosed for nearly 
half of the patients with an acute febrile illness occurring within 
6 weeks following a tick bite. Many of these patients met strict 
case-definition criteria for each disease. Relatively often, evi- 
dence of concurrent or past infection with >1 tickborne or- 
ganism was found. Investigations that include younger patients 
are warranted to more clearly define the public health impor- 
tance of disease caused by tickborne pathogens in Slovenia. 
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